Protective effect of Alhagi sparsifolia against acetaminophen-induced liver injury in mice by Aierken, Aili et al.
Aierken et al 
641 
 
Tropical Journal of Pharmaceutical Research April 2018; 17 (4): 641-646 
ISSN: 1596-5996 (print); 1596-9827 (electronic) 
© Pharmacotherapy Group, Faculty of Pharmacy, University of Benin, Benin City, 300001 Nigeria.  
 
Available online at http://www.tjpr.org 
http://dx.doi.org/10.4314/tjpr.v17i4.11 
Original Research Article 
 
 
Protective effect of Alhagi sparsifolia against 
acetaminophen-induced liver injury in mice 
 
Aili Aierken1, Zhihui Jiang2,3, Kuerbanjiang Maimaitimin1, Mikeremu 
Shayibuzhati1, Xiaoying Zhang1-3* 
1College of Veterinary Medicine, Xinjiang Agricultural University, Urumqi, Xinjiang, 830052, 2College of Veterinary Medicine, 
Northwest A&F University, Yangling, Shaanxi, 712100, 3Research Center of Modern Biotechnology, School of Biotechnology 
and Food Engineering, Anyang Institute of Technology, Anyang, Henan, 455000, China 
 
*For correspondence: Email: zhang.xy@nwsuaf.edu.cn zhxying@yahoo.com; Tel/Fax: +86 29 8709 1239 
 
Sent for review: 31 January 2017        Revised accepted: 14 March 2018 
 
Abstract 
Purpose: To investigate the hepatoprotective effects of Alhagi sparsifolia extract against 
acetaminophen (APAP)-induced liver injury in mice.  
Methods: Three doses of Alhagi sparsifolia (600, 300 and 150 mg/kg) were were administered to 
separate groups of mice orally once a day for three days. One-hour after the last dose, APAP (300 
mg/kg) was intraperitoneally injected. Liver tissue was taken and tested for levels of serum aspartate 
aminotransferase (AST) and alanine transaminase (ALT) as biomarkers of liver injury; malonaldehyde 
(MDA); hydrogen peroxide (H2O2); glutathione (GSH) as an indicator of liver redox; and antioxidant 
enzyme activity using super oxide dismutase (SOD) assay. Additionally, western blotting was used to 
measure the expression of protein cytochrome P450 2E1 (CYP2E1) as the key enzyme of APAP 
metabolism. 
Results: Blood serum of ALT and AST and levels of CYP2E1 were markedly reduced, while the levels 
of MDA, H2O2, and SOD were elevated in a dose-dependent manner in mice treated with Alhagi 
sparsifolia compared to control group treated with APAP alone. 
Conclusion: The results demonstrate that Alhagi sparsifolia protects mice liver tissue against APAP-
induced hepatic injury partly via decreased oxidative stress and inhibition of CYP2E1 expression. 
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Acute liver failure (ALF) is a devastating 
syndrome characterized by sudden loss of innate 
immunity which results in sudden cessation of 
normal liver function and multiple organ failures 
[1]. An intentional or accidental overdose is a 
critical factor in drug-induced liver injury (DILI), 
and the most clinically relevant drugs causing 
DILI is acetaminophen (APAP) [2]. APAP is one 
of the most widely used of the analgesic and 
antipyretic drugs; an overdose of APAP causes 
DILI in humans and animals [3,4]. It is also 
responsible for about 45,000 emergency cases 
per year in the United States [5]. 
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The liver is the primary location of APAP 
metabolism, using CYP enzymatic systems. 
Hepatic cytochrome P450 2E1, 12A, and 3A4 
can potentially metabolize APAP to the toxic inter 
mediate product, N-acetyl-P-benzo-quinoneimine 
(NAPQI) [6], Which could in turn, combine with 
superoxide dismutase (SOD), glutathione (GSH),  
or cellularly important biological macro-molecules 
to induce liver cell death [7]. An APAP overdose 
increases mitochondrial dysfunction, and 
oxidative stress as well as increasing the 
formation of reactive oxygen species (ROS), 
which leads to acute liver injury with hepatocyte 
necrosis, mitochondrial DNA damage, apoptosis 
and nitration of mitochondrial proteins [8]. 
Previously, a large number of medicinal plants 
have been investigated for hepatoprotective 
effects against APAP-induced liver damage. 
 
Alhagi sparsifolia (Ci Tang in Chinese, or 
Taranjebin in Uyghur) is also a well-known herb 
that is mainly distributed in the Xinjiang Uyghur 
autonomous region, it is widely used in Chinese 
traditional medicine to treat a number of 
disorders like arheumatism, cancer, and liver 
disorder and stomach disorders [9,10]. Uyghur 
ethno medicine describes, Alhagi sparsifolia as 
an antipyretic and anti-diarrhea that can be used 
without worries of toxicity [11]. Previous research 
has demonstrated that Alhagi sparsifolia 
possesses various pharmaceutical properties 
that provide benefits as an anti-inflammatory, 
antiviral, antibacterial, antihypertensive, 
hepatoprotective, and immunomodulatory agent 
[12-14]. To date, however, this herbal plant has 
only minimally been studied for its role as a 
hepatoprotective mechanism.  
 
Hence, this study was conducted to focus on its 
novel effects of Alhagi sparsifolia on APAP-





Plant material and preparation 
 
Alhagi sparsifolia (harvested from the Turpan 
basin) was purchased from Xinjiang Uyghur 
Autonomous Region Uyghur Medicine Hospital in 
Xinjiang, China. Ten (10) grams of Alhagi 
sparsifolia was mixed with 200 mL of distilled 
water and boiled for 2 h in a round-bottomed 
flask. The supernatant was collected in a 
separate container, and the pellet was mixed 
with 100 mL of distilled water and again boiled 
for 1.5 h to collect supernatant. Finally, 
supernatants were mixed, filtered and the filtrate 




Five-week old Kun-Ming (KM) female mice (28 ± 
2 g) were purchased from the Experimental 
Animal Center of the Fourth Military Medical 
University (Xi’an, China). All mice were 
maintained in a conventional sanitary facility, with 
the required consistent temperature and relative 
humidity. All animal experimental protocols were 
reviewed and approved by the Ethics Committee 
(no. 2015-mkrm01) of Northwest A&F University 
for the use of Laboratory Animals. We also 
followed the international guidelines for animal 
studies [15]. Mice were acclimatized to the 
laboratory conditions for two weeks prior to the 
experiment. Animals Unlimited access to 
standard food and distilled water (dH2O), 
maintained at a laboratory temperature (22 ± 2 
°C) and humidity (70 ± 4) % as well as 12 h 
light/12 h darkness cycle. 
 
Animals and treatments 
 
A total of 56 female mice were randomly divided 
into eight groups of seven animals each (n = 7). 
The negative control (NC) group received only 
0.9 % physiological saline; the APAP group 
received 300 mg/kg APAP intraperitoneally; and 
the high, middle, and low dose Alhagi-honey 
groups (AHH, AHM, and AHL, respectively) 
received 600, 300, and 150 mg/kg, respectively, 
of Alhagi sparsifolia  by intragastric 
administration once a day for three consecutive 
days, with 300 mg/kg of APAP 1 h after the last 
administration of Alhagi sparsifolia Positive 
control groups received300 mg/kg silymarin (SL) 
and 300 mg/kg sodium salicylate (SS) followed 
by the same dosage regimen as the Alhagi 
sparsifolia groups.  
 
The experimental animals were fasted overnight, 
weighed, and the mice were then anesthetized 
with chloral hydrate. Liver tissue samples were 
taken, and peritoneal venous blood was collected 
in 1.5 ml EP collection containers. The serum 
was separated from the blood samples by 
centrifugation at 2500 rpm for 10 min at 4 °C and 
stored at -20 °C until further analysis. The 
remaining liver tissues were thoroughly rinsed in 
cold 0.9 % physiological saline and divided into 
small portions, then frozen in liquid nitrogen and 
stored at -80°C for biochemical analysis. 
 
Determination of total polysaccharides in 
Alhagi sparsifolia  
 
Total polysaccharide content was measured in 
the Alhagi sparsifolia using the phenol-sulfuric 
acid method [16]. Also, 0.4 mL of Alhagi 
sparsifolia extract, 1.6 mL of distilled water, 1 mL 
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of 5 % phenol reagent and 5 mL of sulfuric acid 
solution were mixed in 10 mL test tubes. The 
mixture was eventually added to 10mL of distilled 
water and kept at room temperature for 10 min. 
The absorbance of the mixture was measured in 
a spectrophotometer at 490 nm. A standard 
curve for total polysaccharide content was 
prepared using glucose, and the total 
polysaccharide content was expressed as 
milligrams of glucose equivalents per gram of dry 
Alhagi sparsifolia extracts. 
 
Serum alanine transaminase (ALT) and 
aspartate aminotransferase (AST) assays 
 
Enzymatic activities of serum ALT and AST were 
estimated spectrophotometrically using 
commercial diagnostic kits per the 
manufacturer’s protocol (Jiancheng Institute of 
Biotechnology, Nanjing, China). 
 
Determination of hepatic MDA, H2O2, SOD, 
and GSH 
 
Frozen liver tissues were thawed and 
homogenized in ice-cold PBS. The homogenate 
was centrifuged at 3,000 rpm for 10 min at 4 °C 
and the supernatants were assayed for MDA, 
H2O2, SOD, and GSH levels using commercial 
assay kits as per the manufacturer’s instructions 
(Jiancheng Bioengineering Institute, Nanjing, 
China). The protein concentrations in tissue 
homogenates were measured using a Bradford 
protein assay with bovine serum albumin as 
standard (Tiangen Biotech, Beijing, China). 
 
Western blot analysis 
 
The microsomal preparation was carried out 
according to the method [15], and the protein 
concentration was using the BCA assay. Proteins 
were resolved by SDS-PAGE and transferred to 
PVDF membranes (Millipore Corporation, 
Boston, MA, USA). After blocking in TBST 
containing 5 % skimmed milk powder, the 
membranes were incubated overnight at 4 °C 
with primary antibodies against cleaved CYP2E1 
(1:800) (Boster, Wuhan, China) and 
glyceraldehyde phosphate dehydrogenase 
(GAPDH, 1:1,000) (Tianjin Sungene Biotech, 
Tianjin, China). Blots were then incubated with a 
1:1000 dilution of horseradish peroxidase 
conjugated secondary antibodies (Sungene 
Biotech, Tianjin, China) for 2 h at room 
temperature. Protein bands were visualized by 
ECL reaction (Genshare Biological, Xian, China). 
The protein levels were quantified using Gel-Pro 
Analyzer software (Media Cybernetics, 




All experimental data are expressed as mean ± 
SD. Significant differences from control in all 
experiments were assessed by one-way analysis 
of variance (ANOVA) using SPSS (IBM 
Corporation, Chicago, IL, USA), and  P < 0.05 




Total polysaccharide content 
 
The values of the standard sample showed a 
linear relation: y = 0.15x - 0.013 (R² = 0.991) for 
glucose. The total polysaccharide content in the 
extract was 692.20 ± 28.16 mg/g. 
 
Alhagi sparsifolia protects against APAP-
induced hepatic dysfunction 
 
Serum AST and ALT activities were significantly 
increased in the APAP-treated group compared 
with the control group, confirming the 
hepatotoxicity of APAP (Figure 1). In the group 
that received APAP following pretreatment with 
Alhagi sparsifolia serum (600, 300 and 150 
mg/kg), ALT and AST activities were significantly 
reduced compared with the APAP group, 
indicating that Alhagi sparsifolia protected 




Figure 1: Effect of Alhagi sparsifolia on APAP-induced 
increase in serum transaminases levels. Note: Mice 
were administered different concentrations of Alhagi 
sparsifolia for three days before of 300 mg/kg APAP 
ip. Blood serum was collected 24 h after APAP 
injection. Each data expressed as mean ± SD (n = 7), 
##p < 0.01 compared with the NC group; *p < 0.05 and 
**p < 0.01 compared with the APAP administrated 
group 
 
Alhagi sparsifolia inhibits APAP-induced 
oxidative stress in mice liver 
 
APAP administration resulted in significant 
increases in MDA and H2O2 levels by 207.7 and 
95.3 % respectively, when compared to the 
normal control group. Treatment with AHH-APAP 
inhibited the increase of MDA and H2O2 level by 
108.5 and 205.8 %, respectively (Figures 2A and 
2B). In the APAP group, the concentration of 
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SOD and GSH were significantly reduced by 
19.1 and 39.4 % when compared to the normal 
control group. Treatment with AHH-APAP 
increased SOD and GSH levels by 8.3 and 40.8 




Figure 2: Alhagi sparsifolia reduced APAP-induced 
oxidative stress. Note: Mice were intragastrically 
administered different concentrations of Alhagi 
sparsifolia for three days before of 300 mg/kg APAP 
ip. Liver tissue was collected 24 h after APAP 
injection. Data expressed as mean ± SD (n = 7), ##p < 
0.01 and ###p <0.001compared with the NC group; *p < 
0.05, **p < 0.01, and ***p < 0.01 compared with the 
APAP administrated group 
 
Effect of .Alhagi sparsifolia on CYP2E1 
protein expression 
 
As shown in Figure 3, the expression levels of 
CYP2E1 in the APAP group were increased 
compared with the NC group (p < 0.001). The 
CYP2E1 level was decreased in the 




Figure 3: Effect of Alhagi sparsifolia on inhibition of 
CYP2E1 protein expression. Note: Mice were 
intragastrically administered different concentrations of 
Alhagi sparsifolia for three days, before of 300 mg/kg 
APAP ip. Liver tissue was collected 24 h after the 
APAP injection. Data are expressed as mean ± SD (n 
= 7), ##p < 0.01 and ###p < 0.001compared with the NC 
group; *p < 0.05, **p < 0.01, and ***p < 0.01 compared 




Alhagi sparsifolia has been investigated for 
biological properties with therapeutic applications 
with various objectives. A previous study has 
illustrated that, Alhagi sparsifolia could attenuate 
carbon tetrachloride induced liver damage and 
drug induced acute liver failure. It has been 
speculated that the anti-oxidant properties of 
Alhagi sparsifolia might be responsible for its 
hepatoprotective effects [17]. 
In the present study, the levels of serum ALT and 
AST, as biomarkers of hepatic function, were 
significantly increased in the group treated with 
APAP-alone. ALT and AST are simple and 
widely accepted biomarkers for hepatic 
dysfunction, indicating that the APAP-induced 
liver damage model was successfully developed 
in mice [14]. In the Alhagi sparsifolia treatment 
group, the serum level of AST and ALT were 
markedly attenuate has compared to the APAP 
treatment group, suggesting that Alhagi 
sparsifolia has potential for use as APAP 
intervention.  
 
Oxidative stress and lipid peroxidation play key 
roles in the occurrence and development of ALF. 
APAP oxidation in the liver produces many 
oxidative stress ROS products, such as 
superoxide anion radical, hydroxyethyl radicals, 
OH- and H2O2. The decreased hepatic 
antioxidant status is related to oxidative stress 
and the elevation of lipid peroxidation; this could 
have resulted in the leakage of hepatic enzymes 
into serum in the animals that received only 
APAP [18]. A key protective action against 
APAP-induced liver injury is through anti-oxidant 
enzymes including GSH and SOD. These 
preventive antioxidants play a major role in 
protecting cells against oxidative stress during 
APAP metabolism, making them the first line of 
defense against oxidative injury. In this study, 
pretreatment with Alhagi sparsifolia significantly 
improved the survival rates of mice, inhibited the 
APAP-induced GSH and SOD depletion as well 
as improved the cell membrane stability. 
 
Oxidative stress and lipid peroxidation play a key 
role in the occurrence and development of ALF. 
APAP oxidation in the liver produces a number of 
oxidative stress ROS products, such as 
superoxide anion radicals, hydroxyethyl radicals, 
OH-, and H2O2. The accumulation of H2O2 
exacerbates cell injury via lipid peroxidation, and 
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MDA is a reliable biomarker of lipid peroxidation 
[19]. In the present study, APAP-induced toxicity 
increased MDA and H2O2 levels in liver tissue as 
compared to the normal group. However, 
treatment with Alhagi sparsifolia significantly 
decreased the MDA and H2O2 levels in 
comparison with the negative control group. 
 
In addition to the direct anti-oxidant properties, 
researchers have also focused on the influence 
of flavonoids on CYP450 enzymes [20]. CYP2E1 
plays a key role in xenobiotic toxicity because it 
produces reactive metabolites and releases 
significant amounts of ROS during the course of 
its catalytic cycle [21]. Previous studies have 
shown that CYP2E1 plays etiological roles in the 
development of drug induced liver damage 
because the accumulation of mitochondrial 
CYP2E1 may be associated with the generation 
of ROS [22]. In addition, the increased 
mitochondrial CYP2E1 expression might have 
some harmful effects on hepatocytes [23]. A 
large number of natural products and their active 
substances could strongly inhibit the expression 
of CYP2E1 [24]. The findings in this study back 
that idea, where Alhagi sparsifolia treated groups 
had reduced CYP2E1 protein expression at a 
microsomal. It has also reported that 
polysaccharides and flavonoids are CYP450 
inhibitor against protein expression [25]. 
Likewise, in this study, Alhagi sparsifolia 
dramatically reduced mitochondrial and 
microsomal CYP2E1 protein levels in APAP and 
Alhagi sparsifolia treated hepatocytes as 




In this study, Alhagi sparsifolia significantly 
attenuated APAP by enhancing the antioxidative 
defense and scavenging ROS, by decreasing the 
blood serum levels of transaminase (ALT and 
AST), and by reducing CYP2E1 expression. 
Consequently, Alhagi sparsifolia is a potential 
hepatoprotective agent against APAP-induced 
liver injury. However, further investigations are 
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